Drug intelligence / Profile preview

EXOB-001

Development stage
Phase 2
Lead developer
EXO Biologics
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intratracheal
01

Overview

EXOB-001 is an investigational exosome-based therapy consisting of extracellular vesicles (EVs) derived from cultured human allogeneic umbilical cord mesenchymal stromal cells (hMSCs). It is being developed for the prevention of bronchopulmonary dysplasia (BPD) in preterm newborns. The drug is administered via intratracheal instillation, delivering EVs directly into the lungs. These vesicles are believed to reduce inflammation and promote tissue repair and regeneration by modulating immune responses, potentially preventing or reducing the severity of BPD. EXOB-001 has received Orphan Drug Designation from both the FDA and EMA for this indication and is currently undergoing Phase 1/2 clinical trials in extremely premature infants[1][2][3][4][5][8].

Other names
Allogeneic umbilical cord mesenchymal stromal cell-derived extracellular vesiclesMSC-derived exosomesUmbilical cord mesenchymal cells-derived extracellular vesicles

Beyond the preview

Go deeper on EXOB-001.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EXOB-001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call